Eli Lilly just unlocked a 20-million patient market.
How the new Medicare GLP-1 Bridge impacts healthcare breakouts.

📰 In This Issue…
The market is shifting. Over the last few weeks, primary AI and tech stocks took a much-needed, heavy hit as institutional algorithms harvested profits from an over-extended sector. But that capital isn't sitting on the sidelines—money is aggressively diversifying and rotating straight into beaten-down value plays and defensive giants.
The biggest fundamental news of the week dropped on Friday: the government officially launched the Medicare GLP-1 Bridge program. Starting July 1, Zepbound and Foundayo will be available to eligible Medicare Part D members for a flat $50 monthly copay. The market had spent six months pricing in government pushback as a major headwind for weight-loss drugs. Instead, this policy shift instantly unlocks a massive 20-million patient volume tailwind, sending mega-cap pharma surging to new All-Time Highs.
Amateur traders get chopped up trying to buy the news after the fact, or forcing long trades in a cooling tech sector. But we stick to our golden rule: The market does not reward activity. It rewards positioning.
We don't chase headlines; we let the news act as the validation for the massive, multi-month bases we have already been mapping. The healthcare leaders on today's list have spent months coiling, shaking out weak retail hands, and quietly building institutional support. Now, the fundamental news has caught up with the technical charts, and the breakout volume is pouring in.
Here are the exact setups we are positioning for today.
Best Stocks To Buy Today
$LLY ( â–² 7.13% ) Long Term Trade
-
The Company Profile: Eli Lilly is a global pharmaceutical titan and undisputed market leader in cardiometabolic health and oncology. They just scored a massive double-catalyst: positive European regulatory backing for their leukemia drug Jaypirca, and broad Medicare $50/month coverage for their blockbuster weight-loss drugs, dramatically expanding their total addressable market.
-
The Macro/Monthly View: The stock has carved out a massive Base-on-Base structure on the monthly chart, forming a tight 5-month consolidation sitting directly on top of a previous 15-month base. Remember the rule: big bases lead to big moves!
-
The Daily/Weekly Setup: We just witnessed a deliberate retail shakeout followed by an immediate, authoritative recovery of the key 50-Day Moving Average.
-
The Trigger: The stock broke out, pulled back in an orderly fashion to test and confirm the structural breakout level, and then exploded to new All-Time Highs backed by a massive 235% Relative Volume surge. It remains one of the absolute strongest healthcare stocks on the planet, displaying extreme relative strength while the broader market was weak.
-
💡 Tip: Use $ELIL for a 2x leveraged ETF.
LLY Monthly and Daily
LLY Daily
📊 Trading Framework Reminder
Remember: Every long-term investment alert can also be played as a swing trade. When shorting, risk management is even more critical.
🦅 Long-Term Investors (3-12 Month Holds)
-
Entry: Full position on breakdown.
-
Profit Taking: Cover 1/4 to 1/5 at Goal 1.
-
Exit Signal: Close above 20-day EMA (your trend guide) or 50-day EMA.
-
Why? Strong moves are hard to time at the bottom, but the 20EMA acts as a reliable trend filter.
âš¡ Swing Traders (2-6 Week Holds)
-
Entry: Full position on breakdown.
-
Profit Taking: Cover 1/3 at Goal 1.
-
Final Exit: Cover the remainder at Goal 2.
💬 How Did We Do?
We’d love to hear your thoughts on this week’s alert!
Was it helpful? Did anything stand out to you? Your feedback helps us improve and keep delivering top-tier insights.
👉 If you're enjoying your premium membership, consider leaving us a quick review — it means a lot!
Regards,
Valentine



